Voyageur Pharmaceuticals Ltd.
VM
Rank in Stocks
#26171
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based... Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine. It possesses complete ownership of three barium sulfate deposits in British Columbia, Canada, two of which are of a quality appropriate for the pharmaceutical barite sector. Furthermore, Voyageur holds stakes in a valuable brine project in Utah, United States, known for its high concentrations of iodine, lithium, and bromine. The company transitioned from its previous name, Voyageur Minerals Ltd., to Voyageur Pharmaceuticals Ltd. in December 2019. Its corporate headquarters are located in Calgary, Canada.
Share Price
$0.09559959
Last synced: 2026-11-09
Market Cap
$21.76M
Change (1 day)
12.50%
Change (1 year)
-16.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Voyageur Pharmaceuticals Ltd. (VM)
Category
Healthcare
Operating Margin for Voyageur Pharmaceuticals Ltd. (VM)
Operating Margin as of November 2026 TTM: -8,038.56%
According to Voyageur Pharmaceuticals Ltd.'s latest financial reports, its current operating margin (TTM) is -8,038.56%. At the end of 2025 the company had an operating margin of -30,231.56%.
Operating Margin history for Voyageur Pharmaceuticals Ltd. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -8,038.56% | -73.41% |
| 2025 | -30,231.56% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.00% |
DE
|
|
| 19.68% | -100.00% |
DE
|
|
| 13.26% | -100.00% |
JP
|
|
| 17.08% | -100.00% |
CH
|
|
| 14.92% | -100.00% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Voyageur Pharmaceuticals Ltd.'s operating margin
What is Voyageur Pharmaceuticals Ltd.'s operating margin?
Voyageur Pharmaceuticals Ltd.'s operating margin is -8,038.56%, as of Nov 2026.
What was Voyageur Pharmaceuticals Ltd.'s operating margin in 2025?
In 2025, Voyageur Pharmaceuticals Ltd.'s operating margin was -30,231.56%, compared with 0.00% in 2024.
How has Voyageur Pharmaceuticals Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Voyageur Pharmaceuticals Ltd.'s operating margin was highest in 2024 (0.00%) and lowest in 2025 (-30,231.56%).
How does Voyageur Pharmaceuticals Ltd.'s operating margin compare with similar companies?
Voyageur Pharmaceuticals Ltd.'s operating margin (-8,038.56%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.